{"id":17901,"date":"2021-04-29T09:38:20","date_gmt":"2021-04-29T07:38:20","guid":{"rendered":"https:\/\/www.mannheimerswartling.se\/?p=17901"},"modified":"2024-05-29T15:55:42","modified_gmt":"2024-05-29T13:55:42","slug":"kry-sakrar-finansiering-om-300-miljoner-dollar","status":"publish","type":"post","link":"https:\/\/www.mannheimerswartling.se\/uppdrag\/kry-sakrar-finansiering-om-300-miljoner-dollar\/","title":{"rendered":"Kry s\u00e4krar finansiering om 300 miljoner dollar"},"content":{"rendered":"<p class=\"preamble\">Kry, Europas ledande leverant\u00f6r av digitala v\u00e5rdtj\u00e4nster, i Storbritannien och Frankrike verksam som Livi, har s\u00e4krat equity-finansiering med ett belopp om 300 miljoner dollar.<\/p>\n<p>Finansieringsrundan leddes av CPP Investments (CPPIB) och Fidelity Management &amp; Research LLC. I rundan deltog \u00e4ven befintliga aktie\u00e4gare, inklusive Ontario Teachers&#8217; Pension Plan, Index Ventures, Accel, Creandum och Project A.<\/p>\n<p>Finansieringen kommer att anv\u00e4ndas till den fortsatta utvecklingen av Kry som v\u00e5rdleverant\u00f6r, fortsatt mjukvaruutveckling samt fortsatt geografisk expansion. Krys tj\u00e4nster kopplar samman patienter med kvalificerad v\u00e5rdpersonal. Den nya finansieringen inneb\u00e4r att miljontals ytterligare patienter runt om i Europa snart kommer kunna dra nytta av Krys teknologi.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kry, Europas ledande leverant\u00f6r av digitala v\u00e5rdtj\u00e4nster, i Storbritannien och Frankrike verksam som Livi, har s\u00e4krat equity-finansiering med ett belopp om 300 miljoner dollar. Finansieringsrundan\u2026<\/p>\n","protected":false},"author":9,"featured_media":17920,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3469],"tags":[],"class_list":["post-17901","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uppdrag","business-group-emerging-and-growth-companies","business-group-fonder-och-investeringar","business-group-foretagsoverlatelser","business-group-healthcare-and-life-sciences"],"acf":[],"lang":"sv","translations":{"sv":17901,"en":17908},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/17901"}],"collection":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/comments?post=17901"}],"version-history":[{"count":1,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/17901\/revisions"}],"predecessor-version":[{"id":17907,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/17901\/revisions\/17907"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/media\/17920"}],"wp:attachment":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/media?parent=17901"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/categories?post=17901"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/tags?post=17901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}